A single 120 microgram dose of the vaccine generated strong neutralizing antibodies against both subtypes of RSV, called RSV-A and RSV-B, across all groups...
- Pfizer said on Monday its respiratory syncytial virus vaccine Abrysvo generated a strong immune response in a late-stage study of four groups of adults aged 18 and older with a compromised immune system.
Pfizer's vaccine is currently approved for people aged 60 and older and for use in women during the middle of the third trimester of pregnancy to protect their babies. Affiliate Marketing Affiliate Marketing Dublin, Aug. 12, 2024 -- The "U.S. Affiliate Marketing Consumer Attitudes 2024" report has been added to ResearchAndMarkets.com's offering. Despite its uncomplicated value proposition, affiliate marketing is in a constant state of reinvention. This survey of 1,378 US consumers about their attitudes toward advertising and privacy identified a number of trends that could shift the balance of power in affiliate.
NEW YORK, August 12, 2024--Pfizer Inc. today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial MONeT , evaluating two doses of ABRYSVO vaccine in immunocompromised adults aged 18 and older at risk of developing severe respiratory syncytial virus -associated lower respiratory tract disease .
Compromised Immune System Older Adults Respiratory Syncytial Virus Vaccine
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Massachusetts governor says Steward Health Care must give 120-day notice before closing hospitalsBOSTON (AP) — Gov. Maura Healey said Thursday she is pressing Steward Health Care to adhere to a state Department of Public Health regulation that hospital...
Read more »
Calgary bike race and street festival a celebration of Bowness’ resiliencyAbout 120 vendors set up shop while more than 200 cyclists participated in the road race.
Read more »
BEYOND LOCAL: Ontario expanding access to RSV vaccines for children, pregnant womenProvince says infants and high-risk children up to two years old will have access to new immunization to protect against respiratory syncytial virus
Read more »
Ontario offering RSV vaccines to more young children and to pregnant womenOntario is expanding its respiratory virus vaccination program this year for infants, high-risk children and pregnant women ahead of the fall flu season.
Read more »
Ontario expanding access to RSV vaccines for young children, pregnant womenChief Medical Officer of Health Dr. Kieran Moore says the changes should better protect young children from severe outcomes
Read more »
Ontario expanding access to RSV vaccines for young children, pregnant womenOntario is doubling the number of children eligible for vaccination against a virus that can make young kids very sick.
Read more »